Tagprescribing

It’s time to lift the restrictions on medical abortion in Australia – Professor Caroline de Costa

By J Pope
In Crime and law, Pregnancy choices, Reproductive health
1 Min Read
I

The Conversation, April 1, 2019 6.13am AEDT Over the past thirteen years, many Australian women have used the drug mifepristone (RU486) to bring about a medical abortion. Rather than undergoing a surgical abortion in a clinic or hospital operating theatre, a medical abortion is induced by taking drugs prescribed by a doctor. But while mifepristone has been available in Australia since 2006, only...

Read onRead later

Smoking and HIV: what are the risks and what harm reduction strategies do we have at our disposal?

By J Pope
In HIV, People Who Inject Drugs / AOD
2 Min Read
S

AIDS Res Ther. 2018 Dec 12;15(1):26. doi: 10.1186/s12981-018-0213-z. Abstract The World Health Organization estimates that smoking poses one of the greatest global health risks in the general population. Rates of current smoking among people living with HIV (PLHIV) are 2-3 times that of the general population, which contributes to the higher incidence of non-AIDS-related morbidity and mortality...

Read onRead later

Clinical Education Forum Recording: Contraception Update

By J Pope
In Contraception, Gynaecology & andrology, Reproductive health, SHINE SA news & events
1 Min Read
C

SHINE SA, November 2018 Clinicians:  SHINE SA is pleased to present the following Clinical Forum by Dr Amy Moten on the topic of Contraception. This recording is available free of charge, and access is limited to three months only. This forum covers emergency contraception and new formulations of the Pill. 3 Category 2 RACGP Points can be awarded on completion of the forum. Recording length: 1...

Read onRead later

HIV PrEP update & HIV prescriber update in Adelaide

By J Pope
In HIV
2 Min Read
H

ASHM, October 2018 HIV PrEP Update for GPs and Practice Nurses This training will provide GPs, Nurses, and Health Professionals working in primary care an update on strategies available for the prevention of HIV transmission, focusing on prevention particularly pre-exposure prophylaxis (PrEP). – Date Tuesday, 23 October 2018 – Venue Mercure Grosvenor, 125 North Terrace, Adelaide SA...

Read onRead later

New study suggests risk of birth defects in babies born to women on HIV medicine dolutegravir

By J Pope
In Contraception, HIV, Pregnancy choices, Reproductive health
1 Min Read
N

European Medicines Agency, 18/05/2018 The European Medicines Agency (EMA) is evaluating preliminary results from a study which found 4 cases of birth defects such as spina bifida (malformed spinal cord) in babies born to mothers who became pregnant while taking dolutegravir. While EMA is assessing the new evidence it has issued the following precautionary advice: Dolutegravir HIV medicines should...

Read onRead later

HIV PrEP available on PBS in Australia from 1 April / Links to Clinical Resources

By J Pope
In Aboriginal Health, Gay Lesbian & Bisexual Health, HIV, Mental health & sexual health, Multicultural communities, People Who Inject Drugs / AOD, Safer sex, Sexual Activity
2 Min Read
H

Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM), 21 March 2018 ASHM congratulates the Federal Health Minister, the Hon. Greg Hunt’s announcement of a landmark in HIV prevention to approve HIV-prevention drugs – tenofovir with emtricitabine, known as PrEP – on the Pharmaceutical Benefits Scheme from 1 April, thereby providing broader access for any doctor or general...

Read onRead later

Your sidebar area is currently empty. Hurry up and add some widgets.